发明名称 Amine derivatives as protease inhibitors
摘要 <p>The present invention relates to novel alkanoyl-substituted heterocyclic derivatives which are cysteine protease inhibitors; the pharmaceutically acceptable salts and N-oxides thereof; their uses as therapeutic agents and the methods of their making; according to Formal (I) in which: A comprises a heteromonocyclic ring containing 5 to 6 ring member atoms or a fused heteropolycyclic ring system containing 8 to 14 ring member atoms, wherein each ring contains 5 to 7 ring member atoms, X&lt;1&gt; is a ring member carbon atom and each ring member other than X&lt;1&gt; is a carbon atom or a heteroatom, with the proviso that (i) at least one ring member atom is a heteroatom and (ii) when A is a heteromonocyclic radical containing 5 ring member atoms, no more than two of the ring member atoms comprising A are heteroatoms; n is 0, 1, 2 or 3; X&lt;1&gt; is =C- or -CH-; X&lt;2&gt; is a bond or a divalent group of Formula (a) or (b); R&lt;1&gt; - R&lt;8&gt;= as in the application.</p>
申请公布号 EP1516877(A1) 申请公布日期 2005.03.23
申请号 EP20040015656 申请日期 2000.03.15
申请人 AXYS PHARMACEUTICALS, INC. 发明人 MARTICHONOK, VALERI;BURGESS-HENRY, JANA;GRAUPE, MICHAEL;LINK, JOHN O.;MCDOWELL, ROBERT S.;MCGRATH, MARY E.;MOSSMAN, CRAIG J.;PATTERSON, JOHN W.;SAUNDERS, OLIVER L.;ZIPFEL, SHEILA M.;MARTELLI, ARNOLD J.;LAI, JUSTINE;ALDOUS, DAVID J.;HALLEY, FRANK;PICKETT, STEPHEN D.;THURAIRATNAM, SUKANTHINI;TIMM, ANDREAS P.
分类号 A61P9/00;A61K31/42;A61K31/44;A61K45/06;A61P37/00;C07D209/14;C07D213/40;C07D217/04;C07D221/08;C07D233/54;C07D241/12;C07D261/08;C07D263/32;C07D263/56;C07D307/14;C07D307/81;C07D333/20;C07D401/12;C07D405/12;C07D405/14;C07D407/12;C07D409/12;C07D409/14;C07D413/12;C07D413/14;C07D417/06;C07F7/18;(IPC1-7):C07D263/56;C07D263/34 主分类号 A61P9/00
代理机构 代理人
主权项
地址